Alphabet's (GOOG, GOOGL) Google said Wednesday that it has received US Food and Drug Administration clearance for its loss of pulse detection feature, which is available on the Pixel Watch 3.
The feature detects when users have a loss of pulse due to events like cardiac arrest, respiratory failure or overdose, and places a call to emergency services, Google said.
The feature is already available for Pixel Watch 3 users in 14 countries and will be launched in the US at the end of March, the company said.
Google said the smartwatch already has other health features like car crash and fall detection, and irregular heart rhythm notifications.
Price: 177.06, Change: -0.31, Percent Change: -0.18
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。